Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Brody

Showing results (391-400 of 517) with videos related to

Pageof 52
Sort By:
Cancer Research|March 3, 2007
High-throughput screening identifies novel agents eliciting hypersensitivity in Fanconi pathway-deficient cancer cellsEike Gallmeier, Tomas Hucl, Jonathan R Brody, et al.
BMC Cancer|March 23, 2012
Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?Matias E Valsecchi, Thomas Holdbrook, Benjamin E Leiby, et al.
Annals of Surgery|July 5, 2021
The Imperative of Assessing Quality of Life in Patients Presenting to a Pancreaticobiliary Surgery ClinicTheresa P Yeo, Ryan W Fogg, Ayako Shimada, et al.
Cell Death & Disease|July 15, 2016
GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuRH Zhou, A G Telonis, Y Jing, et al.
Molecular Biology of the Cell|December 1, 1996
Structure of pp32, an acidic nuclear protein which inhibits oncogene-induced formation of transformed fociT H Chen, J R Brody, F E Romantsev, et al.
Cell Cycle (Georgetown, Tex.)|May 19, 2009
Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survivalJonathan R Brody, Christina L Costantino, Adam C Berger, et al.
Cancer|November 17, 2011
Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinomaMatias E Valsecchi, Mary McDonald, Jonathan R Brody, et al.
The American Journal of Pathology|May 5, 2009
An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancersAgnieszka K Witkiewicz, Abhijit Dasgupta, Federica Sotgia, et al.
Community Dental Health|May 24, 2021
A scoping review of the roles, training, and impact of community health workers in oral healthD T Garcia, J A Lawson, E R Brody, et al.
Cancer Biology & Therapy|July 21, 2006
A proposed clinical test for monitoring fluoropyrimidine therapy: detection and stability of thymidylate synthase ternary complexesJonathan R Brody, Eike Gallmeier, Kiyoshi Yoshimura, et al.
Pageof 52

Showing results (391-400 of 517) with videos related to

Sort By:
Pageof 52
Cancer Research|March 3, 2007
High-throughput screening identifies novel agents eliciting hypersensitivity in Fanconi pathway-deficient cancer cellsEike Gallmeier, Tomas Hucl, Jonathan R Brody, et al.
BMC Cancer|March 23, 2012
Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?Matias E Valsecchi, Thomas Holdbrook, Benjamin E Leiby, et al.
Annals of Surgery|July 5, 2021
The Imperative of Assessing Quality of Life in Patients Presenting to a Pancreaticobiliary Surgery ClinicTheresa P Yeo, Ryan W Fogg, Ayako Shimada, et al.
Cell Death & Disease|July 15, 2016
GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuRH Zhou, A G Telonis, Y Jing, et al.
Molecular Biology of the Cell|December 1, 1996
Structure of pp32, an acidic nuclear protein which inhibits oncogene-induced formation of transformed fociT H Chen, J R Brody, F E Romantsev, et al.
Cell Cycle (Georgetown, Tex.)|May 19, 2009
Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survivalJonathan R Brody, Christina L Costantino, Adam C Berger, et al.
Cancer|November 17, 2011
Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinomaMatias E Valsecchi, Mary McDonald, Jonathan R Brody, et al.
The American Journal of Pathology|May 5, 2009
An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancersAgnieszka K Witkiewicz, Abhijit Dasgupta, Federica Sotgia, et al.
Community Dental Health|May 24, 2021
A scoping review of the roles, training, and impact of community health workers in oral healthD T Garcia, J A Lawson, E R Brody, et al.
Cancer Biology & Therapy|July 21, 2006
A proposed clinical test for monitoring fluoropyrimidine therapy: detection and stability of thymidylate synthase ternary complexesJonathan R Brody, Eike Gallmeier, Kiyoshi Yoshimura, et al.
Pageof 52